HETEROCYCLIC COMPOUND
The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the description,or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for th...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng ; fre ; ger |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | TAKEUCHI, Kohei OKAMOTO, Rei TOKUNAGA, Norihito KAWASAKI, Masanori MIYAZAKI, Tohru ODA, Tsuneo MIYAMOTO, Naoki KOHARA, Yasuhisa MIYANOHANA, Yuhei SUGIMOTO, Takahiro HATTORI, Yasushi IMAMURA, Keisuke OHRA, Taiichi UYGHUR, Dilhumar FUKUDA, Koichiro KOIKE, Tatsuki HOASHI, Yasutaka KAJITA, Yuichi TERAO, Yoshito ITO, Yoshiteru |
| description | The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the description,or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_EP3896060B1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>EP3896060B1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_EP3896060B13</originalsourceid><addsrcrecordid>eNrjZBD1cA1xDfJ3jnT28XRWcPb3DfAP9XPhYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGFpZmBmYGTobGRCgBAGssHqk</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>HETEROCYCLIC COMPOUND</title><source>esp@cenet</source><creator>TAKEUCHI, Kohei ; OKAMOTO, Rei ; TOKUNAGA, Norihito ; KAWASAKI, Masanori ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYAMOTO, Naoki ; KOHARA, Yasuhisa ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; OHRA, Taiichi ; UYGHUR, Dilhumar ; FUKUDA, Koichiro ; KOIKE, Tatsuki ; HOASHI, Yasutaka ; KAJITA, Yuichi ; TERAO, Yoshito ; ITO, Yoshiteru</creator><creatorcontrib>TAKEUCHI, Kohei ; OKAMOTO, Rei ; TOKUNAGA, Norihito ; KAWASAKI, Masanori ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYAMOTO, Naoki ; KOHARA, Yasuhisa ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; OHRA, Taiichi ; UYGHUR, Dilhumar ; FUKUDA, Koichiro ; KOIKE, Tatsuki ; HOASHI, Yasutaka ; KAJITA, Yuichi ; TERAO, Yoshito ; ITO, Yoshiteru</creatorcontrib><description>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the description,or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</description><language>eng ; fre ; ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2023</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230816&DB=EPODOC&CC=EP&NR=3896060B1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25563,76418</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20230816&DB=EPODOC&CC=EP&NR=3896060B1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>TAKEUCHI, Kohei</creatorcontrib><creatorcontrib>OKAMOTO, Rei</creatorcontrib><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>KAWASAKI, Masanori</creatorcontrib><creatorcontrib>MIYAZAKI, Tohru</creatorcontrib><creatorcontrib>ODA, Tsuneo</creatorcontrib><creatorcontrib>MIYAMOTO, Naoki</creatorcontrib><creatorcontrib>KOHARA, Yasuhisa</creatorcontrib><creatorcontrib>MIYANOHANA, Yuhei</creatorcontrib><creatorcontrib>SUGIMOTO, Takahiro</creatorcontrib><creatorcontrib>HATTORI, Yasushi</creatorcontrib><creatorcontrib>IMAMURA, Keisuke</creatorcontrib><creatorcontrib>OHRA, Taiichi</creatorcontrib><creatorcontrib>UYGHUR, Dilhumar</creatorcontrib><creatorcontrib>FUKUDA, Koichiro</creatorcontrib><creatorcontrib>KOIKE, Tatsuki</creatorcontrib><creatorcontrib>HOASHI, Yasutaka</creatorcontrib><creatorcontrib>KAJITA, Yuichi</creatorcontrib><creatorcontrib>TERAO, Yoshito</creatorcontrib><creatorcontrib>ITO, Yoshiteru</creatorcontrib><title>HETEROCYCLIC COMPOUND</title><description>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the description,or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2023</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZBD1cA1xDfJ3jnT28XRWcPb3DfAP9XPhYWBNS8wpTuWF0twMCm6uIc4euqkF-fGpxQWJyal5qSXxrgHGFpZmBmYGTobGRCgBAGssHqk</recordid><startdate>20230816</startdate><enddate>20230816</enddate><creator>TAKEUCHI, Kohei</creator><creator>OKAMOTO, Rei</creator><creator>TOKUNAGA, Norihito</creator><creator>KAWASAKI, Masanori</creator><creator>MIYAZAKI, Tohru</creator><creator>ODA, Tsuneo</creator><creator>MIYAMOTO, Naoki</creator><creator>KOHARA, Yasuhisa</creator><creator>MIYANOHANA, Yuhei</creator><creator>SUGIMOTO, Takahiro</creator><creator>HATTORI, Yasushi</creator><creator>IMAMURA, Keisuke</creator><creator>OHRA, Taiichi</creator><creator>UYGHUR, Dilhumar</creator><creator>FUKUDA, Koichiro</creator><creator>KOIKE, Tatsuki</creator><creator>HOASHI, Yasutaka</creator><creator>KAJITA, Yuichi</creator><creator>TERAO, Yoshito</creator><creator>ITO, Yoshiteru</creator><scope>EVB</scope></search><sort><creationdate>20230816</creationdate><title>HETEROCYCLIC COMPOUND</title><author>TAKEUCHI, Kohei ; OKAMOTO, Rei ; TOKUNAGA, Norihito ; KAWASAKI, Masanori ; MIYAZAKI, Tohru ; ODA, Tsuneo ; MIYAMOTO, Naoki ; KOHARA, Yasuhisa ; MIYANOHANA, Yuhei ; SUGIMOTO, Takahiro ; HATTORI, Yasushi ; IMAMURA, Keisuke ; OHRA, Taiichi ; UYGHUR, Dilhumar ; FUKUDA, Koichiro ; KOIKE, Tatsuki ; HOASHI, Yasutaka ; KAJITA, Yuichi ; TERAO, Yoshito ; ITO, Yoshiteru</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_EP3896060B13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng ; fre ; ger</language><creationdate>2023</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>TAKEUCHI, Kohei</creatorcontrib><creatorcontrib>OKAMOTO, Rei</creatorcontrib><creatorcontrib>TOKUNAGA, Norihito</creatorcontrib><creatorcontrib>KAWASAKI, Masanori</creatorcontrib><creatorcontrib>MIYAZAKI, Tohru</creatorcontrib><creatorcontrib>ODA, Tsuneo</creatorcontrib><creatorcontrib>MIYAMOTO, Naoki</creatorcontrib><creatorcontrib>KOHARA, Yasuhisa</creatorcontrib><creatorcontrib>MIYANOHANA, Yuhei</creatorcontrib><creatorcontrib>SUGIMOTO, Takahiro</creatorcontrib><creatorcontrib>HATTORI, Yasushi</creatorcontrib><creatorcontrib>IMAMURA, Keisuke</creatorcontrib><creatorcontrib>OHRA, Taiichi</creatorcontrib><creatorcontrib>UYGHUR, Dilhumar</creatorcontrib><creatorcontrib>FUKUDA, Koichiro</creatorcontrib><creatorcontrib>KOIKE, Tatsuki</creatorcontrib><creatorcontrib>HOASHI, Yasutaka</creatorcontrib><creatorcontrib>KAJITA, Yuichi</creatorcontrib><creatorcontrib>TERAO, Yoshito</creatorcontrib><creatorcontrib>ITO, Yoshiteru</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>TAKEUCHI, Kohei</au><au>OKAMOTO, Rei</au><au>TOKUNAGA, Norihito</au><au>KAWASAKI, Masanori</au><au>MIYAZAKI, Tohru</au><au>ODA, Tsuneo</au><au>MIYAMOTO, Naoki</au><au>KOHARA, Yasuhisa</au><au>MIYANOHANA, Yuhei</au><au>SUGIMOTO, Takahiro</au><au>HATTORI, Yasushi</au><au>IMAMURA, Keisuke</au><au>OHRA, Taiichi</au><au>UYGHUR, Dilhumar</au><au>FUKUDA, Koichiro</au><au>KOIKE, Tatsuki</au><au>HOASHI, Yasutaka</au><au>KAJITA, Yuichi</au><au>TERAO, Yoshito</au><au>ITO, Yoshiteru</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>HETEROCYCLIC COMPOUND</title><date>2023-08-16</date><risdate>2023</risdate><abstract>The present invention provides a heterocyclic compound having an orexin type 2 receptor agonist activity.A compound represented by the formula (I):wherein each symbol is as described in the description,or a salt thereof has an orexin type 2 receptor agonist activity, and is useful as an agent for the prophylaxis or treatment of narcolepsy.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng ; fre ; ger |
| recordid | cdi_epo_espacenet_EP3896060B1 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | HETEROCYCLIC COMPOUND |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-08T13%3A19%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=TAKEUCHI,%20Kohei&rft.date=2023-08-16&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EEP3896060B1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |